Prognosis: Breakthrough

Prognosis: Breakthrough

By BloombergScienceHealth & Fitness
Download on the App Store

Prognosis: Breakthrough episodes

  • Will Kids Spread COVID to Teachers?
    Earlier this year, school gates around the world slammed shut. The drastic measure worked in many places. Now, as fall approaches, attention is turning back to a pillar of a pandemic-resilient society: schools. The role of children in driving transmission of the coronavirus isn’t clear, and what we know about past respiratory infections isn’t a lot of help. But, as Bloomberg senior editor Jason Gale finds out, some clearer trends are emerging.
    Learn more about your ad-choices at https://www.iheartpodcastnetwork.com
    17 min
  • The Promise of a New Treatment
    The drug company Eli Lilly is about to start testing its Covid-19 antibody drug in nursing homes. Vaccines may not work as well on elderly people or those with compromised immune systems. Since these are the very groups most at risk for severe disease or death if they contract the coronavirus, a successful antibody treatment could have a marked effect on lowering the pandemic’s death toll. Riley Griffin talks about the new drug, and the promise of antibody treatments.
    Learn more about your ad-choices at https://www.iheartpodcastnetwork.com
    15 min
  • What We Know About Immunity
    In the race to study immunity to the virus, scientists first focused on antibodies -- proteins that stick to and disable foreign invaders. That’s because creating antibodies is the basis for most successful vaccines, so scientists are interested in learning who develops coronavirus antibodies, how long they stick around, and how effective they are at keeping people from getting infected again. But recent studies show there may be another weapon inside the human body that can rouse fresh antibody soldiers long after the first have left the battlefield. Bloomberg senior editor Jason Gale explains that T cells may be part of the key to blunting the coronavirus contagion.
    Learn more about your ad-choices at https://www.iheartpodcastnetwork.com
    14 min
  • The Data Disaster in the U.S.
    More than a month into a resurgence of the novel coronavirus that has besieged Sun Belt states, flooded hospitals and strained public-health infrastructure, the U.S. still lacks a complete picture of the reality on the ground. That’s because the U.S. doesn’t have ANY real-time system to track the virus’s spread. At times, even the federal government has had to rely on third-party databases. Emma Court reports on the danger of a Covid-19 data black hole. 
    Learn more about your ad-choices at https://www.iheartpodcastnetwork.com
    15 min
  • Why a Vaccine Won't Create Instant Immunity
    An effective vaccine is seen as the world’s greatest hope for achieving some kind of return to normal, and the timeline for developing one has been sped up dramatically. But as hard as it’s going to be to make a vaccine quickly, once we do, we’ll have a new problem: Getting it to billions of people. Brendan Murray explains how difficult it will be for the global supply chain to distribute and administer the drug.
    Learn more about your ad-choices at https://www.iheartpodcastnetwork.com
    16 min
  • Why The Crisis Hurts Maine's Lobster Industry
    A few places in the U.S. are still relatively unscathed by the virus, but they haven’t been able to escape the economic devastation. Esmé E. Deprez reports on why the fallout from Covid-19 is devastating Maine's lobster business.
    Learn more about your ad-choices at https://www.iheartpodcastnetwork.com
    13 min
  • The Campaign to Lure You Back to the Doctor
    When physicians and hospitals became overwhelmed with COVID-19 cases, other medical services, from routine tests to emergency room visits, fell dramatically. The long-term consequences of Americans putting off basic medical care may be disastrous. John Tozzi reports on a new push by the health-care industry to stop so-called "Medical Distancing.”
    Learn more about your ad-choices at https://www.iheartpodcastnetwork.com
    18 min
  • The Latin American Country That's Beating Covid
    The small South American nation of Uruguay is best known for its grass-fed beef and Atlantic beaches. But the country of 3.5 million people has another distinction: It seems to have dodged the worst of the Covid-19 outbreak despite being nestled between hotspot countries. The country has seen just 1,000 or so cases since the pandemic began, and only 33 deaths. Ken Parks reports the reasons may have as much to do with its policies from years past, as its present day virus response.
    Learn more about your ad-choices at https://www.iheartpodcastnetwork.com
    15 min
  • The First Vaccine May Not Be the Best
    An experimental Covid vaccine from Australia joined almost two dozen candidates in clinical trials this week. Development-wise, it’s months behind some of the frontrunners. Jason Gale explains that speed isn’t everything when it comes to fighting the pandemic.
    Learn more about your ad-choices at https://www.iheartpodcastnetwork.com
    16 min
  • Introducing: Blood River, A New Podcast From Bloomberg
    The killers of Berta Caceres had every reason to believe they’d get away with murder. More than 100 other environmental activists in Honduras had been killed in the previous five years, yet almost no one had been punished for the crimes. Bloomberg’s Blood River follows a four-year quest to find her killers – a twisting trail that leads into the country’s circles of power.
    Blood River premieres on July 27.
    Learn more about your ad-choices at https://www.iheartpodcastnetwork.com
    6 min

About Prognosis: Breakthrough

From the publisher's feed

On Breakthrough, a new series from the Prognosis podcast, we explore how the pandemic is changing our understanding of healthcare and medicine. We start with an examination of long Covid, a mysterious…